tirzepatide obstructive sleep apnea fda approval 2024 Zepbound just became the first drug ever FDA-approved for (Dec 2024). In the SURMOUNT-OSA trial — NEJM, n=469 — breathing events dropped ~60%, patients lost 18% of their body weight FDA first to approve obesity

Hormonal shifts Weight loss and changes in body composition can influence hormones, including thyroid and sex hormones

Synaptopathies: synaptic dysfunction in neurological disordersA review from students to students

You can find products of wildly varying quality, and for a researcher, that's a catastrophic variable

When peptides are reconstituted, water then becomes a reactive medium

Patients should factor in required lab costs ($75, $200 per panel depending on the test set and lab), telehealth subscription fees, and shipping when calculating total monthly expense

GLP-1 medications can cause side effects ranging from mild nausea to severe complications like pancreatitis or kidney problems